A Phase II Study to Evaluate the Efficacy of IdeS to Desensitize Transplant Patients With a Positive Crossmatch Test

NCT02790437 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Failure, Chronic

Interventions

DRUG: IdeS
PROCEDURE: Kidney transplantation

Sponsor

Hansa Biopharma AB